Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Up 0.5% - Time to Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) shot up 0.5% during mid-day trading on Monday . The stock traded as high as $8.40 and last traded at $8.39. 128,647 shares were traded during mid-day trading, an increase of 18% from the average session volume of 109,074 shares. The stock had previously closed at $8.35.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 1.2%

The firm's 50-day moving average price is $8.34 and its 200-day moving average price is $7.83. The company has a quick ratio of 6.13, a current ratio of 6.63 and a debt-to-equity ratio of 0.01. The company has a market cap of $14.19 billion, a P/E ratio of 14.23, a price-to-earnings-growth ratio of 1.92 and a beta of 0.21.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by ($0.03). The company had revenue of $721.77 million for the quarter, compared to analyst estimates of $824.23 million. As a group, equities research analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.